APLLTDBSEAlembic Pharmaceuticals LtdMediumNeutral
Announced Fri, 1 May · 10:40 IST

Intimation under Regulation 30 of SEBI (LODR), Regulations 2015-Designated as Senior Management Personnel

Management Changes View source PDF

APLLTD · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reaction · full curve 14 horizons · vs prior close
+2.3%1-day move
₹753.00
prior close
₹759.95
base price
After-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
+0.2+0.2+0.8+1.3+2.3+4.2+2.6+4.5+4.9+2.3+0.7-2.3+10.9
Up moveDown movePending
AI summary

Alembic Pharmaceuticals has designated Mr. Amit Nayak, Vice President - Commercial Excellence, as Senior Management Personnel effective 1st May, 2026. Mr. Nayak holds a PGDM from IMT Ghaziabad and a B.Tech in Pharmaceutical Sciences from ICT Mumbai, bringing 12 years of experience in commercial excellence, sales operations, digital enablement, and business development. He previously worked at J B Chemicals & Pharmaceuticals, Cipla, IMS, and EY. The designation is part of SEBI LODR compliance requirements.

Likely market impact

This is a routine internal designation change rather than a major leadership appointment. It formalizes an existing VP's status as a Key Managerial Personnel under securities regulations, with no direct impact on stock price or shareholder value in the near term.